The biomarkers such as CK-18, caspase 3/7 activity, sPD-1, and serum miR-122 levels could be used as adjunctive criteria to diagnose acute hepatitis C more definitively and to provide a sharper case definition for acute hepatitis C. The gene discussed is KRT18; the disease is hepatitis C virus infection.